— Know what they know.
Not Investment Advice

THNR

Amplify Weight Loss Drug & Treatment ETF
1W: -4.4% 1M: -9.0% 3M: -7.5% YTD: -3.4% 1Y: -0.2%
$24.56
-0.13 (-0.54%)
 
Weekly Expected Move ±2.8%
$23 $24 $25 $25 $26
ETF AMEX · AUM $4.9M

Portfolio Health Summary

IS Overall Score
60.7
★★★★★
Altman Z-Score
7.77
Safe
Weight Coverage
93%
of portfolio analyzed
Holdings Matched
18
with fundamental data

InsiderStreet Scorecard

★★★★★ 60.7
Profitability
74.0
Balance Sheet
60.8
Earnings Quality
57.7
Growth
53.9
Value
44.0
Momentum
71.7
Safety
86.2

Top Holdings: Score Breakdown

Risk & Quality Signals

Altman Z-Score
7.77
Safe Zone (>2.99)
Piotroski F-Score
6.0 / 9
Moderate
Beneish M-Score
-0.18
Possible Manipulator
Credit Score
—
Earnings Quality
57.7 / 100

Portfolio Valuation

P/E
20.40x
P/B
5.04x
P/S
5.11x
EV/EBITDA
14.31x
EV/Revenue
5.63x
P/FCF
24.04x
P/OCF
17.77x
PEG
1.17x
Earnings Yield
4.90%
FCF Yield
4.16%
OCF Yield
5.63%
Median P/E
21.78x

Growth & Shareholder Returns

Year-over-Year Growth

Revenue +16.2%
Net Income +7.9%
EPS +16.6%
FCF +38.5%
EBITDA +9.6%
Op. Income —

Compound Growth Rates

Rev CAGR 3Y +34.4%
Rev CAGR 5Y +18.2%
EPS CAGR 3Y +17.5%
EPS CAGR 5Y +16.9%
FCF CAGR 3Y +21.8%
FCF CAGR 5Y +14.0%
EBITDA CAGR 3Y +12.3%
EBITDA CAGR 5Y +11.8%
Payout Ratio
74.92%
Buyback Yield
0.64%
Dividend Yield
2.01%
Total Shareholder Return
1.38%

Earnings Stability

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 594 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$24.56
Median 1Y
$23.86
5th Pctile
$17.19
95th Pctile
$33.21
Ann. Volatility
19.4%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics
Valuation (12)
MetricValue
Portfolio P/E 20.40
Portfolio P/B 5.04
Portfolio P/S 5.11
EV/EBITDA 14.31
EV/Revenue 5.63
P/FCF 24.04
P/OCF 17.77
PEG 1.17
Earnings Yield 4.90%
FCF Yield 4.16%
OCF Yield 5.63%
Median P/E 21.78
Profitability & Returns (9)
MetricValue
Gross Margin 71.11%
Operating Margin 33.45%
Net Margin 24.92%
FCF Margin 21.18%
ROE 25.88%
ROA 15.39%
ROIC 28.16%
ROCE —
Asset Turnover —
Leverage & Solvency (6)
MetricValue
Debt/Equity 0.28
Debt/Assets 0.16
Net Debt/EBITDA -0.27
Interest Coverage 28.13
Current Ratio 2.06
Quick Ratio 1.57
Efficiency (4)
MetricValue
Asset Turnover —
Inventory Turnover —
Receivables Turnover —
Payables Turnover —
Growth — YoY (6)
MetricValue
Revenue Growth 16.25%
Net Income Growth 7.94%
EPS Growth 16.64%
FCF Growth 38.45%
EBITDA Growth 9.60%
Op. Income Growth —
Growth — CAGR (16)
MetricValue
Revenue CAGR 3Y 34.44%
Revenue CAGR 5Y 18.22%
Revenue CAGR 10Y —
EPS CAGR 3Y 17.50%
EPS CAGR 5Y 16.93%
EPS CAGR 10Y —
FCF CAGR 3Y 21.75%
FCF CAGR 5Y 13.97%
FCF CAGR 10Y —
EBITDA CAGR 3Y 12.31%
EBITDA CAGR 5Y 11.79%
EBITDA CAGR 10Y —
Net Income CAGR 3Y 13.97%
Net Income CAGR 5Y 15.40%
Op. Income CAGR 3Y —
Op. Income CAGR 5Y —
Quality Scores (13)
MetricValue
IS Overall 60.7
IS Profitability 74.0
IS Balance Sheet 60.8
IS Earnings Quality 57.7
IS Growth 53.9
IS Value 44.0
IS Momentum 71.7
IS Safety 86.2
IS Quality 73.7
Altman Z-Score 7.77
Piotroski F-Score 6.04
Beneish M-Score -0.18
Credit Score —
Dividends & Payout (4)
MetricValue
Dividend Yield 2.01%
Payout Ratio 74.92%
Buyback Yield 0.64%
Total Shareholder Return 1.38%
Growth Stability (4)
MetricValue
Revenue Stability 0.800
Earnings Stability 0.589
Earnings Persistence 0.655
Margin Stability 0.837
Medians (3)
MetricValue
Median P/E 21.78
Median P/B 4.94
Median Dividend Yield —
Coverage Meta (3)
MetricValue
Weight Coverage % 92.72%
Holdings Matched 18
Total Holdings 21

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms